Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer ...
Singapore: Thermo Scientific has launched CeLLInsight CX5 High Content Screening (HCS) Platform, a high-content quantita...
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leuka...
Singapore: Global pharmaceutical company, Amgen, has plans to reacquire all of its remaining rights from GSK on Prolia (...
Singapore: Aslan Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents fo...
Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IM...
Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to...
Singapore: Mundipharma and Shionogi has announced a new exclusive sales collaboration contract for its ISODINE brand in ...
Singapore: Global medical technology company, Medtronic, has opened a new Asia Pacific regional headquarters in Singapor...
Singapore: A novel technology for aiding the diagnosis of Cancers of Unknown Primary (CUP), by Circadian Technologies, w...
Singapore, a cosmopolitan city state that offers world-class living standards and attracts talent from all over the glob...
Pfizer's 20-person surveillance testing group located in Groton will be relocating to Singapore in 2013. The surveillanc...
Singapore: Mr Raman Singh, president, Mundipharma Asia Pacific, Latin America, the Middle East and Africa, has been rank...
Singapore: Royal Philips and EDBI, the corporate investment arm of the Singapore Economic Development Board, have signed...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Singapore's Inex Innovations Exchange, a fetal health diagnostics company, signed a distribution agreement fo...
Singapore: Singapore-Stanford Biodesign (SSB) has inked a three-year pact with Korea's Dongguk University (DU) to train ...
Singapore: ImaginAb, a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform...
